Mesenchymal Stem Cell Therapy from Bone Marrow and Associated Orthobiologic Treatments
Stem Cell Therapy and Orthopedic
DOI:
https://doi.org/10.5281/zenodo.10553463Keywords:
Stem cell, Regenerative medicine, Mesenchymal stem cellAbstract
The current article's goal is to examine the body of research on the use of bone marrow-derived mesenchymal stem cell treatment to treat musculoskeletal disorders and to highlight the urgent need for more carefully planned clinical trials. Mesenchymal stem cells generated from bone marrow have garnered significant attention in the treatment of musculoskeletal disorders and injuries in recent years. The clinical application of BM-MSCs and other stem cell therapies has progressed well beyond the basic and translational research data needed to clarify the possible effectiveness of this orthobiologic therapeutic strategy. Mesenchymal stem cell therapy derived from bone marrow has shown promise in treating knee osteoarthritis, focal chondral lesions, shoulder pathologies such as glenohumeral arthritis, rotator cuff tears, and degenerative disk disease in the spine. These findings are consistent with early research findings. The majority of research that has been published to date are brief case series that frequently don't have a control group or a set course of therapy. Mesenchymal stem cell therapy produced from bone marrow is becoming a more popular treatment for diseases and accidents related to the musculoskeletal system. Despite encouraging results from early clinical trials, methodological errors and a lack of trial standardization have restricted the inferences that can be made from the body of current research. The effectiveness and usefulness of BM-MSCs as a therapy option for different orthopedic disorders will become clearer with a deeper comprehension of the underlying mechanism of action and more meticulously planned clinical trials.
References
Caplan AI. Mesenchymal stem cells. J Orthop Res Off Publ Orthop Res Soc. 1991;9(5):641–50.
Porada CD, Zanjani ED, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1(3):365–9.
Federal Trade Commission [Internet]. 2018 [cited 2023 Nov 2]. FTC Stops Deceptive Health Claims by a Stem Cell Therapy Clinic. Available from: https://www.ftc.gov/news-events/news/press-releases/2018/10/ftc-stops-deceptive-health-claims-stem-cell-therapy-clinic
McIntyre JA, Jones IA, Han B, Vangsness CT. Intra-articular Mesenchymal Stem Cell Therapy for the Human Joint: A Systematic Review. Am J Sports Med. 2018;46(14):3550–63.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.
Caplan AI. Mesenchymal Stem Cells: Time to Change the Name! Stem Cells Transl Med. 2017;6(6):1445–51.
Guimarães-Camboa N, Cattaneo P, Sun Y, Moore-Morris T, Gu Y, Dalton ND, et al. Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell. 2017;20(3):345-359.e5.
Kingery MT, Manjunath AK, Anil U, Strauss EJ. Bone Marrow Mesenchymal Stem Cell Therapy and Related Bone Marrow-Derived Orthobiologic Therapeutics. Curr Rev Musculoskelet Med. 2019;12(4):451–9.
Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–53.
Emadedin M, Ghorbani Liastani M, Fazeli R, Mohseni F, Moghadasali R, Mardpour S, et al. Long-Term Follow-up of Intra-articular Injection of Autologous Mesenchymal Stem Cells in Patients with Knee, Ankle, or Hip Osteoarthritis. Arch Iran Med. 2015;18(6):336–44.
Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95(12):1535–41.
Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation. 2014;97(11):e66-68.
Vega A, Martín-Ferrero MA, Del Canto F, Alberca M, García V, Munar A, et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015;99(8):1681–90.
Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002;10(3):199–206.
Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med. 2007;1(1):74–9.
Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110–6.
Haleem AM, Singergy AAE, Sabry D, Atta HM, Rashed LA, Chu CR, et al. The Clinical Use of Human Culture–Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects. Cartilage. 2010;1(4):253–61.
Stein BE, Stroh DA, Schon LC. Outcomes of acute Achilles tendon rupture repair with bone marrow aspirate concentrate augmentation. Int Orthop. 2015;39(5):901–5.
Gessmann J, Köller M, Godry H, Schildhauer TA, Seybold D. Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev. 2012;4(1):e14.
Petri M, Namazian A, Wilke F, Ettinger M, Stübig T, Brand S, et al. Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: a clinical and positron emission tomography--computed tomography analysis. Int Orthop. 2013;37(11):2231–7.
Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Bone. 2011;49(5):1005–9.
Singh A, Gangwar DS, Singh S. Bone marrow injection: A novel treatment for tennis elbow. J Nat Sci Biol Med. 2014;5(2):389–91.
Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD. A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. J Pain Res. 2015;8:269–76.
Hernigou P, Flouzat Lachaniette CH, Delambre J, Zilber S, Duffiet P, Chevallier N, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38(9):1811–8.
Giannini S, Buda R, Vannini F, Cavallo M, Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop. 2009;467(12):3307–20.
Buda R, Vannini F, Cavallo M, Baldassarri M, Natali S, Castagnini F, et al. One-step bone marrow-derived cell transplantation in talarosteochondral lesions: mid-term results. Joints. 2013;1(3):102–7.
Jones IA, Chen X, Evseenko D, Vangsness CT. Nomenclature Inconsistency and Selective Outcome Reporting Hinder Understanding of Stem Cell Therapy for the Knee. J Bone Joint Surg Am. 2019;101(2):186–95.
Piuzzi NS, Hussain ZB, Chahla J, Cinque ME, Moatshe G, Mantripragada VP, et al. Variability in the Preparation, Reporting, and Use of Bone Marrow Aspirate Concentrate in Musculoskeletal Disorders: A Systematic Review of the Clinical Orthopaedic Literature. J Bone Joint Surg Am. 2018;100(6):517–25.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ulus Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
